Table 3 Disease specific standardized mortality ratios for HCV serological groups vs. BC population
From: Mortality among British Columbians testing for hepatitis C antibody
| Â | Â | SNR (n=342,325) | MNR (n=73,476) | REAC (n=27,812) | SERO (n=2,408) | All HCV +ve (n=30,220) |
|---|---|---|---|---|---|---|
ICD-10 | Cause of death | SMR (95% CI) | SMR (95% CI) | SMR (95% CI) | SMR (95% CI) | SMR (95% CI) |
A00-B99 | Infection | 1.57 (1.38 - 1.78) | 4.36 (3.55 - 5.30) | 31.51 (29.08 - 34.09) | 32.09 (19.32 - 50.05) | 31.53 (29.14 - 34.07) |
C00-D48 | Neoplasms | 1.35 (1.31 - 1.40) | 1.72 (1.59 - 1.87) | 2.35 (2.14 - 2.59) | 1.98 (0.73 - 4.31) | 2.35 (2.13 - 2.58) |
D50-D89 | Blood/immune | 1.82 (1.33 - 2.43) | 5.18 (2.83 - 8.71) | 7.91 (4.09 - 13.84) | 36.40 (0.92 - 202.75) | 8.41 (4.48 - 14.39) |
E00-E90 | Endocrine | 1.82 (1.67 - 1.97) | 5.29 (4.58 - 6.07) | 2.07 (1.48 - 2.82) | 3.21 (0.08 - 17.87) | 2.09 (1.50 - 2.83) |
F00-F99 | Mental and behavioural | 1.16 (1.02 - 1.31) | 2.61 (1.99 - 3.37) | 6.79 (5.43 - 8.37) | 16.01 (4.35 - 40.98) | 6.96 (5.60 - 8.55) |
G00-G99 | Nervous system | 1.05 (0.95 - 1.17) | 1.49 (1.11 - 1.95) | 1.78 (1.21 - 2.53) | 6.96 (0.84 - 25.11) | 1.87 (1.29 - 2.62) |
I00-I99 | Circulatory system | 1.42 (1.38 - 1.46) | 2.22 (2.06 - 2.40) | 2.21 (1.98 - 2.45) | 6.04 (3.01 - 10.81) | 2.25 (2.03 - 2.50) |
J00-J99 | Respiratory system | 1.29 (1.22 - 1.37) | 1.70 (1.44 - 1.99) | 2.96 (2.46 - 3.53) | 5.36 (0.65 - 19.36) | 2.98 (2.48 - 3.55) |
K00-K93 | Digestive system | 2.36 (2.20 - 2.53) | 7.40 (6.60 - 8.27) | 7.97 (6.91 - 9.14) | 10.26 (3.33 - 23.92) | 8.01 (6.96 - 9.17) |
N00-N99 | Genitourinary system | 1.95 (1.74 - 2.17) | 10.47 (8.96 - 12.16) | 4.54 (3.14 - 6.34) | 12.21 (0.31 - 68.02) | 4.62 (3.22 - 6.42) |
R00-R99 | Other | 0.92 (0.68 - 1.22) | 3.48 (2.25 - 5.15) | 7.43 (5.15 - 10.39) | 21.58 (5.87 - 55.24) | 7.99 (5.65 - 10.96) |
V01-Y98 | External | 1.44 (1.34 - 1.54) | 2.64 (2.34 - 2.98) | 8.58 (7.96 - 9.22) | 15.25 (11.72 - 19.51) | 8.88 (8.28 - 9.52) |